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ObjectiveaaAttention-deficit/hyperactivity disorder (ADHD) is a complex neurodevelopmental disorder with a strong genetic compo-
nent. Brain-derived neurotrophic factor (BDNF), which participates in the differentiation and survival of dopaminergic and noradren-
ergic neurons, could play a role in ADHD development. We aimed to explore the relationships between ADHD and BDNF gene poly-
morphism.
MethodsaaWe conducted a case-control analysis of 202 ADHD subjects and 159 controls, performed a transmission disequilibrium test 
on 151 trios, and compared the results of a continuous performance test (CPT) according to the genotype of the three single nucleotide 
polymorphisms (rs11030101, rs6265, rs16917204) in the BDNF gene.
ResultsaaIn the case-control analysis, the AA genotype of the BDNF rs11030101 polymorphism was significantly associated with ADHD 
only in girls (p=0.024, odds ratio=3.00). The T-G-G haplotype was significantly less frequent (p=0.005) and A-G-G was more frequent 
(p=0.048) in girls with ADHD than in control girls (global p=0.027). A multivariate analysis of variance for commission errors on the CPT 
showed a significant main effect for the rs11030101 genotype (p=0.026) and an interaction effect of the rs11030101 genotype and gender 
(p=0.032) in ADHD probands.
ConclusionaaThese results provide preliminary evidence for a gender-specific association between BDNF and ADHD in the Korean 
population. 
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INTRODUCTION
Attention-deficit/hyperactivity disorder (ADHD), which af-
fects about 5% of school-aged children worldwide,
1 is a neuro-
developmental disorder characterized by inattention, hyperac-
tivity, and impulsivity. ADHD causes social, academic, and be-
havioral problems and persists into adulthood in 30-50% of 
cases.
1 Familial and genetic studies strongly support a role for 
a genetic component in ADHD pathogenesis, and the estimat-
ed heritability is approximately 80%.
2
The catecholamine systems have been implicated in the patho-
physiology of ADHD, and genes modulating dopamine and 
norepinephrine system have been studied extensively.
2 Never-
theless, evidence from neurobiological and pharmacological re-
search supports the role of neurotrophic factors in ADHD pa-
thogenesis. Given that ADHD is a neurodevelopmental dis-
order, neurotrophic factors supporting neuronal survival, pro-
liferation, and differentiation, as well as survival and synaptic 
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plasticity in the central nervous system,
3 might be involved in 
ADHD susceptibility. Among neurotrophic factors, brain-de-
rived neurotrophic factor (BDNF), which is critical for the sur-
vival and differentiation of midbrain dopaminergic neurons
4 
and the phenotypic differentiation of locus ceruleus noradren-
ergic neurons,
5 has been a focus. 
BDNF messenger RNA is expressed in the mesolimbic do-
paminergic system, the prefrontal cortex, the limbic system, 
and the cerebellum,
3 which have been implicated in ADHD 
pathogenesis. BDNF gene expression is reduced in the frontal 
cortex of dopamine transporter knockout mice, which is con-
sidered as an animal model for ADHD.
6 BDNF conditional 
knockout mice exhibit increased locomotor hyperactivity, 
which mimics the fundamental behavioral characteristics of 
ADHD.
7 Moreover, BDNF mediates psychostimulant-induced 
neuroadaptations and locomotor activity through the dopami-
nergic, serotoninergic, and noradrenergic neurotransmitter sys-
tems.
8 A recent study reported a positive correlation between 
plasma BDNF levels and severity of omission errors on the con-
tinuous performance test (CPT) in patients with ADHD.
9
Previous studies have shown inconsistent results regarding 
the relationship between the BDNF gene and ADHD. Case-
control studies
8,10,11 have shown negative results, but in one stu-
dy,
11 a haplotype containing the rs6265 G allele increased sig-
nificantly in children with ADHD. Family-based association 
analyses are also not in agreement.
10-13 In quantitative trait anal-
ysis, there is some evidence of association of parent-rated symp-
toms and cognitive functions.
14 However, no study has investi-
gated the association between the BDNF gene and the results of 
the CPT. 
Thus, we aimed to evaluate the relationships between ADHD 
and BDNF gene polymorphisms by conducting case-control 
and family-based association studies of the BDNF gene and by 
comparing the results of the CPT based on the genotype of the 
BDNF gene in a Korean sample.
METHODS
The subjects with ADHD and their parents were recruited 
through the Department of Child and Adolescent Psychiatry at 
three university-affiliated hospitals in Korea (Seoul National, 
Kyungpook National, and Chungbuk National Hospitals). All 
subjects with ADHD met the following inclusion criteria: 1) 
DSM-IV diagnosis of ADHD; 2) above the 90
th percentile in 
the ADHD Rating Scale-IV (ARS);
15 3) T-scores greater than 
60 on the attention problems profile of the Child Behavior 
Checklist (CBCL);
16 and 4) intelligence quotient (IQ) higher 
than 71 on the Korean Educational Developmental Institute’s 
Wechsler Intelligence Scale for Children (KEDI-WISC).
17
The control group was recruited from nine elementary schools 
in Seoul, Incheon, Seongnam, Ulan, and Yeoncheon, Korea. 
The children selected for the control group 1) did not meet the 
criteria for the DSM-IV diagnosis of ADHD; 2) scored below 
the 90
th percentile on the ARS; 3) had T-scores of less than 60 on 
the attention problems profile of the CBCL; and 4) had IQ 
scores higher than 71 on the KEDI-WISC.
Subjects were excluded from the study if they had one or 
more of the following: 1) past and/or current history of neurologi-
cal disorder, including seizure disorder or brain damage; and 
2) presence of comorbid psychosis, Tourette’s, bipolar, commu-
nication, learning, or pervasive developmental disorder.
We obtained written informed consent from the parents of 
all children who participated in the study and approval from the 
institutional review boards at each institution where the study 
was performed.
The diagnoses of ADHD and comorbid disorders of the ADHD 
subjects were determined using the Korean version of the Sche-
dule for Affective Disorders and Schizophrenia for School-
Aged Children-Present and Lifetime Version (K-SADS-PL-K).
18 
The children in the control group did not meet the criteria for 
ADHD according to the Korean version of the Diagnostic Inter-
view Schedule for Children Version-IV (DISC-IV).
19,20
A computerized CPT was used to measure cognitive func-
tions.
21 A visual stimulus was presented every 2 sec for 100 ms, 
and subjects were asked to respond to a square containing a tri-
angle (target), but not to a square containing a circle or a square 
(nontarget). The target stimulus was presented in 22.5% of the 
trials during the first half and in 77.5% of the trials during the 
second half of the CPT. The four major variables recorded were 
1) omission errors, 2) commission errors, 3) response time, and 
4) the standard deviations of the response time for correct re-
sponses to the target (response time variability).
Genomic DNA was extracted from blood (stored frozen) us-
ing the G-DEX
TM II Genomic DNA Extraction Kit (Intron, Seong-
nam, Korea). The detection of a single nucleotide polymorphism 
(SNP) was based on analysis of primer extension products gen-
erated from previously amplified genomic DNA using a chip-
based MALDI-TOF mass spectrometry platform (Sequenom, 
Inc., San Diego, CA, USA). All primers in the PCR and hME re-
actions were designed using Assay Designer 3.1 (Sequenom) (5’- 
ACGTTGGATGGCTTGACATCATTGGCTGAC and 5’-AC-
GTTGGATGTTTTCTTCATTGGGCCGAAC for the rs6265; 
5’-ACGTTGGATGACCCACCAGAAAGCTCAATC and 5’- 
ACGTTGGATGTCCTGTTTCTAATCACAGGG for the 
rs16917204; 5’-ACGTTGGATGCCTGTAAAACAGGATG-
GCTC and 5’-ACGTTGGATGATGGCTCCAGGAAAGAG 
TTC for the rs11030101).
We tested the family-based and case-control associations for 
each individual polymorphism and haplotype using the stan-
dard transmission disequilibrium test (TDT) method in Hap-SC Cho et al. 
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loview (http://www.broad.mit.edu/mpg/haploview/) or SNPA-
lyzer software ver 7.0 (Dynacom, Chiba, Japan). Multivariate 
analysis of variance (MANOVA) was computed to examine the 
effect of BDNF genotype and gender on the result of the CPT. 
SPSS (ver. 15.0) was used for the analysis.
RESULTS
This study included 202 subjects with ADHD (9.0±2.5 years) 
and 159 normal children (9.0±2.7 years) for the case-control 
analysis. Table 1 illustrates demographic and clinical character-
istics of ADHD and control subjects. The mean ages of the two 
groups were not significantly different (p=0.924). The gender 
distribution of the two groups did differ significantly; 174 
ADHD subjects and 111 normal controls were boys (χ2=14.67, 
p<0.001). Thus, the case-control and family-based analyses of 
boys and girls were conducted separately. The mean age, IQ, in-
attention, hyperactivity and total scores of ARS, and ADHD 
subtype were not significantly different between genders (p= 
0.797, 0.714, 0.531, 0.981, 0.755, 0.088, respectively). Comorbid-
ity with oppositional defiant, conduct, mood, anxiety disorder, 
and enuresis were not different between genders (p= 0.773, 1, 1, 
0.087, 0.652, respectively). All participants were ethnically Ko-
rean. The family-based analysis included 151 trios consisting of 
an affected subject and his or her biological father and mother. 
The genotype distribution of the three SNPs did not deviate 
from expectations based on the Hardy-Weinberg equilibrium 
(p>0.05). In a case-control analysis, the A allele and AA geno-
type of the rs11030101 were significantly higher in girls with 
ADHD than in control girls. The odds ratios of the A allele and 
AA genotype were 2.64 [95% confidence interval (CI)=1.19-5.88] 
and 3.00 (95% CI=1.14-7.91), respectively. We found no signifi-
cant differences between the ADHD and control groups in the 
genotype or allele frequencies for boys or in other polymor-
phisms (Table 2).
The results of the linkage disequilibrium analysis revealed 
that the three BDNF SNPs were in strong disequilibrium 
(rs11030101-rs16917204, r
2=0.328; rs16917204-rs6265, r
2=0.404; 
rs11030101-rs6265, r
2=0.864). In the haplotype analysis (Table 
3), the T-G-G haplotype was significantly less frequent (p=0.005) 
and A-G-G was more frequent (p=0.048) in girls with ADHD 
than in control girls (p-value for global test=0.027). We found 
no significant differences in haplotype frequency in the ADHD 
and control boys.
The TDT analysis showed a trend toward the preferential 
transmission of the A allele of the BDNF rs6265 polymorphism 
(p=0.059) in girls (Table 4). No preferential transmission was 
found for boys or in other polymorphisms.
A total of 173 ADHD subjects without missing data were in-
cluded in the MANOVA to examine the effect of BDNF geno-
type and gender on the CPT results. 
We found no significant differences between excluded and 
included subjects with regard to demographic and clinical char-
acteristics. The MANOVA for commission errors on the CPT 
showed a significant main effect of the rs11030101 genotype 
(F1=5.028, p=0.026) and an interaction effect of the rs11030101 
genotype and gender (F1= 4.679, p=0.032) in ADHD probands 
(Table 5).
Table 1. Demographic and clinical characteristics of the subjects with ADHD and controls
ADHD (N=202) Control (N=159) t or χ2 p-value
Age in yr, mean (SD) 009.0 (2.5) 009.0 (0.7)  -0.06   0.924
Gender, boys, N (%) 0 174 (86.1%) 0 111 (69.8%) 14.67 <0.001
IQ, mean (SD) 106.2 (14.8) 114.8 (15.3) 05.33 <0.001
ADHD rating scale
    Inattention score 014.3 (6.2)  004.9 (4.8)  14.66 <0.001
    Hyperactivity score 010.5 (6.0)  003.2 (4.1)  12.36 <0.001
    Total score 024.8 (10.5)  008.1 (8.3)  15.21 <0.001
Child behavior checklist (CBCL)
    Withdrawn 058.3 (8.2)  053.0 (8.1)  05.63 <0.001
    Somatic complaints 053.3 (5.0)  051.8 (3.5)  02.91   0.004 
    Anxious/Depressed 056.9 (7.5)  051.7 (5.0)  07.01 <0.001
    Social problems 061.2 (9.4)  051.3 (4.2)  11.86 <0.001
    Thought problems 057.3 (7.7)  051.6 (5.1)  07.56 <0.001
    Attention Problems 061.4 (8.0)  051.4 (3.7)  13.91 <0.001
    Delinquent behaviors 055.4 (6.4)  050.9 (4.7)  06.95 <0.001
    Aggressive behaviors 060.0 (8.9)  051.0 (4.3)  11.24 <0.001
ADHD: attention-deficit/hyperactivity disorder, BDNF: brain-derived neurotrophic factor, IQ: intelligence quotient288  Psychiatry Investig 2010;7:285-290
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DISCUSSION
In our case-control and haplotype analyses, BDNF polymor-
phism was associated with ADHD in girls. The rs11030101 
polymorphism was significantly related to commission errors, 
especially in girls. Thus, the results of this study suggest a gen-
der-specific association of the BDNF gene with ADHD.
This gender-specific association of BDNF is in agreement 
with the well-known gender differences in the prevalence, 
course, and clinical features of ADHD.
22 Recent studies suggest 
Table 2. Comparison of the allele frequencies of BDNF polymorphisms between ADHD probands and controls
Marker
Cases, N (%) Controls, N (%) χ
2 
(2 df) p
Cases, N (%) Controls, N (%) χ2
(1 df) p
11 12 22 11 12 22 1 2 1 2
rs11030101 Boys 80 
(46.0)
76 
(43.7)
18 
(10.3)
54 
(48.6)
43 
(38.7)
14 
(12.6)
0.810 0.667 236 
(67.8)
112 
(32.2)
151 
(68.0)
71 
(32.0)
0 0.960
Girls 18 
(64.3)
10 
(35.7)
0 
(0)
18 
(37.5)
25 
(52.1)
5 
(10.4)
0.035*
 
46 
(82.1)
10 
(17.9)
61 
(63.5)
35 
(36.5)
5.87 0.015
rs6265 Boys 56 
(32.2)
84 
(48.3)
34 
(19.5)
34 
(30.6)
51 
(45.9)
26 
(23.4)
0.615 0.735 196 
(56.3)
152 
(43.7)
119 
(53.6)
103 
(46.4)
0.405 0.525
Girls 4 
(14.3)
15 
(53.6)
9 
(32.1)
12 
(25.0)
23 
(47.9)
13 
(27.1)
1.234 0.578 23 
(41.1)
33 
(58.9)
47 
(49.0)
49 
(51.0)
0.886 0.347
rs16917204 Boys 58 
(33.3)
82 
(47.1)
34 
(19.5)
36 
(32.4)
51 
(45.9)
24 
(21.6)
0.181 0.913 198 
(56.9)
150 
(43.1)
123 
(55.4)
99 
(44.6)
0.123 0.726
Girls 5 
(17.9)
15 
(53.6)
8 
(28.6)
12 
(25.0)
24 
(50.0)
12 
(25.0)
0.533 0.766 25 
(44.6)
31 
(55.4)
48 
(50.0)
48 
(50.0)
0.407 0.524
*comparisons were assessed using the Fisher’s exact test. ADHD: attention-deficit/hyperactivity disorder, BDNF: brain-derived neurotrophic 
factor, 1: major allele (A for rs11030101, G for rs6265, G for rs16917204,), 2: minor allele
that many genes including BDNF, or the genetic variations 
within them, may act differently in males and females.
23 Stud-
ies that have examined the sexually dimorphic effects of genes 
in ADHD have also been increasing.
24,25
Many of these gender effects may be the result of hormonal 
influences on gene expression and regulation or other non-ge-
netic factors that are correlated with gender. In the case of 
BDNF, sex hormones may influence the activity and expression 
of BDNF-producing cortical neurons. In an animal model, es-
trogen was reported to regulate BDNF expression by directly 
interacting with an estrogen response element-like sequence
26 
and by indirectly modulating GABAergic interneurons.
27 Un-
fortunately, the mechanisms by which estrogen affects the de-
veloping human brain are ill defined. However, because estro-
gen levels differ between genders during the prepubertal period 
as well as during the prenatal period and after puberty,
28 estro-
gen could contribute to the gender-specific modulation of BDNF 
gene in children with ADHD.
Moreover, our results are congruent with sexual dimorphism 
in brain structures involved in the neurobiology of ADHD, par-
Table 3. Haplotype distribution of the three BDNF SNPs (rs11030101/rs6265/rs16917204)
Haplotype
(rs11030101/
rs6265/rs16917204)
Boys Girls
Frequency Haplotype 
specific p
Global
p
Frequency Haplotype 
specific p
Global
p Cases Controls Cases Controls
A-C-A 0.419 0.427 0.857 0.633 0.554 0.500 0.533 0.027
T-G-G 0.310 0.301 0.817 0.179 0.365 0.005
A-G-G 0.241 0.216 0.495 0.232 0.125 0.048
A-G-A 0.014 0.037 0.108 0.036 0.010 0.276
T-C-G 0.012 0.019 0.522
BDNF: brain-derived neurotrophic factor, SNP: single nucleotide polymorphism
Table 4. Transmission disequilibrium test results for BDNF rs6265 
polymorphism in ADHD girls (20 trios)
Transmitted
A G
Not transmitted A 10 5
G 13 12
Comparisons were assessed using the McNemar’s χ2 test (χ2=3.56, 
df=1, p=0.059). ADHD: attention-deficit/hyperactivity disorder, 
BDNF: brain-derived neurotrophic factorSC Cho et al. 
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ticularly the prefrontal cortex. Brain development is known to 
differ between genders in typically developing children and ad-
olescents, and this difference is more evident in the prefrontal 
cortex.
29 Involvement of the prefrontal cortex is one of the best-
replicated findings with respect to brain regions associated with 
ADHD,
30 and there is emerging evidence that the trajectories of 
early anomalous development of prefrontal cortex in ADHD is 
gender-specific.
22 The BDNF gene has been reported to be as-
sociated with volume of prefrontal cortex both in animal
31 and 
in human studies.
32
The rs11030101 polymorphism is located within the BDNF 
intron and has no obvious functional consequences. Howev-
er, in this study, strong linkage disequilibrium was observed 
with rs6265, also known as the Val66Met SNP, which causes an 
amino acid substitution of valine to methionine. Met-BDNF 
alters intracellular trafficking and activity-dependent secretion 
in neurosecretory cells and cortical neurons.
33
Several limitations of this study should be noted. First, the 
sample size of this study was relatively small, and only 28 ADHD 
and 48 control girls were included in the case-control analysis, 
which was small to avoid a sample bias. Second, there were sig-
nificant differences between the ADHD and control groups with 
regard to gender and IQ. Although we performed the case-
control and family-based analyses of boys and girls separately, 
the difference in IQ between the two groups could influence 
our results. Third, the association of BDNF and ADHD in the 
case-control analysis and MANOVA did not persist after cor-
rection for multiple testing. Fourth, the diagnosis of the ADHD 
subjects and controls was based on different diagnostic inter-
view tools (K-SADS-PL-K or DISC-IV). However, good diag-
nostic validities have been established for both instruments, 
and the same rating scales (K-ARS and CBCL) were applied for 
diagnosis in both groups. Further studies with a greater num-
ber of subjects, especially girls, are required to validate our re-
sults.
Despite these caveats, the results of this study provide pre-
liminary evidence for the sexually dimorphic effects of the 
BDNF gene among Korean patients with ADHD.
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